These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 35617508)
1. Hepatitis A in the Eastern Mediterranean Region: a comprehensive review. Badur S; Öztürk S; AbdelGhany M; Khalaf M; Lagoubi Y; Ozudogru O; Hanif K; Saha D Hum Vaccin Immunother; 2022 Nov; 18(5):2073146. PubMed ID: 35617508 [TBL] [Abstract][Full Text] [Related]
2. A new method for imputing country-level estimates of hepatitis A virus endemicity levels in the Eastern Mediterranean region. Itani T; Jacobsen KH; Nguyen T; Wiktor SZ Vaccine; 2014 Oct; 32(46):6067-74. PubMed ID: 25236586 [TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
4. Modeling the hepatitis A epidemiological transition in Brazil and Mexico. Van Effelterre T; Guignard A; Marano C; Rojas R; Jacobsen KH Hum Vaccin Immunother; 2017 Aug; 13(8):1942-1951. PubMed ID: 28481680 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Jacobsen KH; Wiersma ST Vaccine; 2010 Sep; 28(41):6653-7. PubMed ID: 20723630 [TBL] [Abstract][Full Text] [Related]
6. A review of the experience of childhood hepatitis A vaccination in Saudi Arabia and Turkey: implications for hepatitis A control and prevention in the Middle East and North African region. Badur S; Öztürk S; Ozakay A; Khalaf M; Saha D; Van Damme P Hum Vaccin Immunother; 2021 Oct; 17(10):3710-3728. PubMed ID: 34213403 [TBL] [Abstract][Full Text] [Related]
7. Seroprevalence and incidence of hepatitis A in Southeast Asia: A systematic review. Hernandez-Suarez G; Saha D; Lodroño K; Boonmahittisut P; Taniwijaya S; Saha A; Badur S; Poovorawan Y PLoS One; 2021; 16(12):e0258659. PubMed ID: 34851983 [TBL] [Abstract][Full Text] [Related]
8. Challenges in Management of Hepatitis A Virus Epidemiological Transition in Mexico. Trujillo-Ochoa JL; Viera-Segura O; Fierro NA Ann Hepatol; 2019; 18(1):14-22. PubMed ID: 31113583 [TBL] [Abstract][Full Text] [Related]
9. Immunity to Hepatitis-A virus: A nationwide population-based seroprevalence study from Iran. Lankarani KB; Honarvar B; Molavi Vardanjani H; Kharmandar A; Gouya MM; Zahraei SM; Baneshi MR; Ali-Akbarpour M; Kazemi M; Seif M; Fard SAZ; Emami A Vaccine; 2020 Oct; 38(45):7100-7107. PubMed ID: 32917416 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis A in Latin America: The current scenario. Ré VE; Ridruejo E; Fantilli AC; Moutinho BD; Pisano MB; Pessoa MG Rev Med Virol; 2024 Jul; 34(4):e2566. PubMed ID: 38970225 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis A: Epidemiology, High-Risk Groups, Prevention and Research on Antiviral Treatment. Migueres M; Lhomme S; Izopet J Viruses; 2021 Sep; 13(10):. PubMed ID: 34696330 [TBL] [Abstract][Full Text] [Related]
12. Seroprevalence and Shifting Endemicities of Hepatitis A Virus Infection in Two Different Geographical Areas in the Philippines. Carlos JC; Quinones VMT; Adversario MPL; Nailes JM; Songco JC; Garcia DR; Cacayorin MG; Cero MPV; Benedicto-Delfin MPA; Blanco MCC; Natividad NS; Bernabe JD; Chacon HCT; Ascue RAC; Paggao JNK; Comendador LOP; Hernandez-Suarez G; Guzman-Holst A Infect Dis Ther; 2024 May; 13(5):1019-1035. PubMed ID: 38578515 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis A seroprevalence, vaccination status and demographic determinants in children and adolescents in Germany, 2014-2017, a population-based study. Enkelmann J; Kuhnert R; Stark K; Faber M Sci Rep; 2023 Jun; 13(1):9762. PubMed ID: 37328526 [TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of hepatitis A virus in a cross-sectional study in Mexico: Implications for hepatitis A vaccination. Lazcano-Ponce E; Conde-Gonzalez C; Rojas R; DeAntonio R; Romano-Mazzotti L; Cervantes Y; Ortega-Barria E Hum Vaccin Immunother; 2013 Feb; 9(2):375-81. PubMed ID: 23291940 [TBL] [Abstract][Full Text] [Related]
15. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations. Ceyhan M; Yildirim I; Kurt N; Uysal G; Dikici B; Ecevit C; Aydogan A; Koc A; Yasa O; Köseoğlu M; Onal K; Hacimustafaoglu M; Celebi S J Viral Hepat; 2008 Oct; 15 Suppl 2():69-72. PubMed ID: 18837839 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis A virus infection and hepatitis A vaccination in human immunodeficiency virus-positive patients: A review. Lin KY; Chen GJ; Lee YL; Huang YC; Cheng A; Sun HY; Chang SY; Liu CE; Hung CC World J Gastroenterol; 2017 May; 23(20):3589-3606. PubMed ID: 28611512 [TBL] [Abstract][Full Text] [Related]
17. The changing pattern of hepatitis A in Lebanese adults. Melhem NM; Jaffa M; Zaatari M; Awada H; Salibi NE; Ramia S Int J Infect Dis; 2015 Jan; 30():87-90. PubMed ID: 25448334 [TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of hepatitis A virus antibodies (anti-HAV) in adult inhabitants of Wielkopolska region, Poland--the role of simple demographic factors. Bura M; Bura A; Adamek A; Michalak M; Marszałek A; Hryckiewicz K; Mozer-Lisewska I Ann Agric Environ Med; 2012; 19(4):738-41. PubMed ID: 23311799 [TBL] [Abstract][Full Text] [Related]
19. Epidemiology of hepatitis A in Mediterranean countries. Papaevangelou G Vaccine; 1992; 10 Suppl 1():S63-6. PubMed ID: 1335662 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis A in Puglia (South Italy) after 10 years of universal vaccination: need for strict monitoring and catch-up vaccination. Chironna M; Prato R; Sallustio A; Martinelli D; Tafuri S; Quarto M; Germinario C BMC Infect Dis; 2012 Oct; 12():271. PubMed ID: 23098290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]